Home/Entera Bio/Dr. Richard B. Mazess
DR

Dr. Richard B. Mazess

Director

Entera Bio

Entera Bio Pipeline

DrugIndicationPhase
EB613Osteoporosis (postmenopausal women)Phase 3
EB612HypoparathyroidismPhase 2
EBP05OsteoporosisPreclinical